Outcomes in patients with chronic myelogenous leukemia (CML).

Cumulative incidence of nonrelapse mortality (A) and relapse (B) and actuarial probability of survival (C) and leukemia-free survival (D) after HLA-identical sibling bone marrow transplantation for CML in first chronic phase, according to whether pretransplantation treatment was with interferon-α with or without hydroxyurea or hydroxyurea alone. P values were calculated with the log-rank test.